BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38418719)

  • 21. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-positive women with anal high-grade squamous intraepithelial lesions: a study of 153 cases with long-term anogenital surveillance.
    Liu Y; Prasad-Hayes M; Ganz EM; Poggio JL; Lenskaya V; Malcolm T; Deshmukh A; Zheng W; Sigel K; Gaisa MM
    Mod Pathol; 2020 Aug; 33(8):1589-1594. PubMed ID: 32152521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.
    Guo M; Gong Y; Wang J; Dawlett M; Patel S; Liu P; Bevers TB; Sneige N
    Cancer Cytopathol; 2013 Feb; 121(2):79-85. PubMed ID: 23225501
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
    Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
    J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis.
    Matsuo K; Blake EA; Machida H; Mandelbaum RS; Roman LD; Wright JD
    Gynecol Oncol; 2018 Sep; 150(3):501-508. PubMed ID: 30054103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV.
    Tachezy R; Smahelova J; Salakova M; Arbyn M; Rob L; Skapa P; Jirasek T; Hamsikova E
    PLoS One; 2011; 6(7):e21913. PubMed ID: 21765924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and Type-Distribution of Human Papillomavirus in Vulva and Vaginal Abnormal Cytology Lesions and Cancer Tissues from Thai Women.
    Ngamkham J; Boonmark K; Phansri T
    Asian Pac J Cancer Prev; 2016; 17(3):1129-34. PubMed ID: 27039737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.
    Garland SM; Joura EA; Ault KA; Bosch FX; Brown DR; Castellsagué X; Ferenczy A; Ferris DG; Giuliano AR; Hernandez-Avila M; Huh WK; Iversen OE; Kjaer SK; Kurman RJ; Luna J; Monsonego J; Muñoz N; Paavonen J; Pitisuttihum P; Ronnett BM; Steben M; Stoler MH; Wheeler CM; Wiley DJ; Perez G; Saah AJ; Luxembourg A; Li S; DiNubile MJ; Wagner M; Velicer C
    Obstet Gynecol; 2018 Aug; 132(2):261-270. PubMed ID: 29995724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV Screening Test for the Detection of Precancerous Cervical Lesions and Cervical Cancer in Israeli Women.
    Feinberg T; Yehuda-Shnaidman E; Wolf T; Sandbank J; Segal J; Vaknin Z; Schejter E
    Acta Cytol; 2021; 65(6):494-500. PubMed ID: 34515031
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we predict histological outcome of distinctive cohorts of patients with glandular cell abnormalities on ThinPrep Papanicolaou testing based on human papillomavirus status, age, and associated squamous abnormalities?
    Harbhajanka A; Dahoud W; Michael CW
    Diagn Cytopathol; 2019 Oct; 47(10):1028-1036. PubMed ID: 31359607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
    Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
    JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.
    Balamurugan A; Ahmed F; Saraiya M; Kosary C; Schwenn M; Cokkinides V; Flowers L; Pollack LA
    Cancer; 2008 Nov; 113(10 Suppl):2919-25. PubMed ID: 18980275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
    Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
    Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancers attributable to human papillomavirus infection.
    Grulich AE; Jin F; Conway EL; Stein AN; Hocking J
    Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
    Castle PE; Solomon D; Schiffman M; Wheeler CM
    J Natl Cancer Inst; 2005 Jul; 97(14):1066-71. PubMed ID: 16030304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
    Zhao C; Zhao S; Heider A; Austin RM
    Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers.
    Bjørge T; Dillner J; Anttila T; Engeland A; Hakulinen T; Jellum E; Lehtinen M; Luostarinen T; Paavonen J; Pukkala E; Sapp M; Schiller J; Youngman L; Thoresen S
    BMJ; 1997 Sep; 315(7109):646-9. PubMed ID: 9310566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
    J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.
    Suk R; Mahale P; Sonawane K; Sikora AG; Chhatwal J; Schmeler KM; Sigel K; Cantor SB; Chiao EY; Deshmukh AA
    JAMA Netw Open; 2018 Sep; 1(5):e181999. PubMed ID: 30646145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers.
    Cameron JE; Rositch AF; Vielot NA; Mugo NR; Kwatampora JKL; Waweru W; Gilliland AE; Hagensee ME; Smith JS
    Sex Transm Dis; 2018 Oct; 45(10):666-672. PubMed ID: 29664764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.